Integra LifeSciences Holdings Corp. Company Profile (NASDAQ:IART)

About Integra LifeSciences Holdings Corp.

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: Health Care Equipment
Exchange: NASDAQ
Symbol: IART
CUSIP: 45798520

Key Metrics:

Previous Close: $85.67
50 Day Moving Average: $85.67
200 Day Moving Average: $76.08
52-Week Range: $54.75 - $88.86
Trailing P/E Ratio: 354.01
Foreward P/E Ratio: 21.58
P/E Growth: 2.05
Market Cap: $3.20B
Outstanding Shares: 37,360,000
Beta: 0.52

Profitability:

Net Margins: 0.79%
Return on Equity: 15.41%
Return on Assets: 6.49%

Debt:

Debt-to-Equity Ratio: 0.86%
Current Ratio: 3.30%
Quick Ratio: 1.83%

Additional Links:

Companies Related to Integra LifeSciences Holdings Corp.:

Consensus Ratings for Integra LifeSciences Holdings Corp. (NASDAQ:IART) (?)

Ratings Breakdown:	2 Hold Ratings, 6 Buy Ratings
Consensus Rating:	Buy (Score: 2.75)
Consensus Price Target:	$86.29 (0.72% upside)

Analysts' Ratings History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)

Show:

Date	Firm	Action	Rating	Price Target
9/23/2016	Argus	Boost Price Target	Buy	$90.00 -> $105.00
8/21/2016	Piper Jaffray Cos.	Reiterated Rating	Overweight	$86.00 -> $94.00
7/29/2016	Jefferies Group	Boost Price Target	Buy	$81.00 -> $95.00
7/29/2016	Barclays PLC	Boost Price Target	Equal Weight	$77.00 -> $84.00
7/13/2016	JPMorgan Chase & Co.	Initiated Coverage	Overweight
4/28/2016	Oppenheimer Holdings Inc.	Reiterated Rating	Buy
4/28/2016	Lake Street Capital	Boost Price Target	Hold	$57.00 -> $75.00
11/12/2015	Citigroup Inc.	Initiated Coverage	Buy	$75.00
9/21/2015	Bank of America Corp.	Upgrade	Neutral -> Buy	$72.00 -> $79.00
7/29/2015	Raymond James Financial Inc.	Upgrade	Market Perform -> Outperform
5/4/2015	Royal Bank Of Canada	Boost Price Target	Sector Perform	$62.00 -> $66.00
5/1/2015	Wells Fargo & Co.	Upgrade	Market Perform -> Outperform

(Data available from 9/27/2014 forward)

Earnings History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/1/2016
7/28/2016	Q216	$0.76	$0.79	$243.17 million	$249.30 million	View	Listen
4/27/2016	Q116	$0.73	$0.74	$230.66 million	$236.80 million	View	Listen
2/25/2016	Q4	$0.86	$0.87	$241.11 million	$241.20 million	View	Listen
11/3/2015	Q315	$0.74	$0.75	$224.08 million	$226.40 million	View	Listen
7/30/2015	Q215	$0.75	$0.79	$239.91 million	$244.10 million	View	Listen
4/30/2015	Q115	$0.63	$0.76	$229.69 million	$233.70 million	View	N/A
2/24/2015	Q414	$0.89	$0.94	$244.39 million	$252.20 million	View	Listen
11/3/2014	Q314	$0.74	$0.76	$233.50 million	$229.70 million	View	Listen
8/5/2014	Q214	$0.64	$0.68	$229.32 million	$231.40 million	View	N/A
5/1/2014	Q114	$0.58	$0.57	$213.30 million	$215.00 million	View	N/A
2/25/2014	Q413	$0.81	$0.78	$223.37 million	$220.80 million	View	N/A
10/28/2013	Q313	$0.70	$0.72	$214.05 million	$213.20 million	View	N/A
8/1/2013	Q2 2013	$0.55	$0.60	$207.30 million	$205.50 million	View	N/A
5/2/2013	Q1 2013	$0.37	$0.39	$195.20 million	$196.70 million	View	N/A
2/21/2013	Q4 2012	$0.76	$0.78	$215.90 million	$214.40 million	View	N/A
10/24/2012		$0.77	$0.85			View	N/A
7/26/2012		$0.69	$0.74			View	N/A
4/25/2012		$0.60	$0.71			View	N/A
2/23/2012		$0.55	$0.72			View	N/A
10/31/2011		$0.77	$0.77			View	N/A
7/28/2011		$0.61	$0.70			View	N/A
4/28/2011		$0.66	$0.66			View	N/A
2/24/2011		$0.73	$0.80			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Integra LifeSciences Holdings Corp. (NASDAQ:IART)

Current Year EPS Consensus Estimate: $3.48 EPS
Next Year EPS Consensus Estimate: $3.97 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	7	$0.72	$0.85	$0.78
Q2 2016	4	$0.76	$0.85	$0.80
Q3 2016	4	$0.87	$0.92	$0.90
Q4 2016	5	$1.00	$1.06	$1.03
Q1 2017	3	$0.86	$0.98	$0.92
Q2 2017	3	$0.83	$0.99	$0.90
Q3 2017	3	$0.84	$1.05	$0.97
Q4 2017	3	$0.96	$1.17	$1.09

(Data provided by Zacks Investment Research)

Dividend History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)

Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 88.32%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/23/2016	Raymond G Murphy	Director	Sell	2,600	$86.64	$225,264.00
8/9/2016	Peter J Arduini	CEO	Sell	24,009	$84.52	$2,029,240.68
8/4/2016	Raymond G Murphy	Director	Sell	2,610	$84.83	$221,406.30
8/1/2016	Richard D Gorelick	VP	Sell	4,000	$84.60	$338,400.00
5/9/2016	Joseph Vinhais	VP	Sell	972	$73.36	$71,305.92
5/4/2016	Glenn Coleman	CFO	Sell	3,563	$70.62	$251,619.06
5/3/2016	Christian S Schade	Director	Sell	7,829	$70.42	$551,318.18
5/2/2016	Daniel L Reuvers	VP	Sell	1,000	$71.43	$71,430.00
4/29/2016	Richard D Gorelick	VP	Sell	4,000	$70.72	$282,880.00
4/27/2016	Stuart Essig	Director	Sell	104,390	$70.15	$7,322,958.50
4/6/2016	Stuart Essig	Director	Sell	21,100	$66.19	$1,396,609.00
4/5/2016	Stuart Essig	Director	Sell	83,290	$66.68	$5,553,777.20
4/4/2016	Stuart Essig	Director	Sell	42,150	$67.26	$2,835,009.00
5/7/2015	Stuart Essig	Director	Sell	75,000	$64.32	$4,824,000.00
5/6/2015	Stuart Essig	Director	Sell	125,000	$64.83	$8,103,750.00
1/2/2015	Judith Ogrady	VP	Sell	3,500	$53.33	$186,655.00
10/28/2014	Stuart Essig	Director	Sell	147,098	$49.58	$7,293,118.84
10/27/2014	Stuart Essig	Director	Sell	41,268	$49.56	$2,045,242.08
9/2/2014	Judith Ogrady	VP	Sell	2,500	$49.82	$124,550.00
8/27/2014	Richard D Gorelick	VP	Sell	7,000	$50.03	$350,210.00
8/25/2014	John B Henneman III	CAO	Sell	20,000	$50.12	$1,002,400.00
8/22/2014	Deborah A Leonetti	VP	Sell	1,000	$50.96	$50,960.00
8/8/2014	Brian Larkin	VP	Sell	1,947	$48.28	$94,001.16
7/30/2014	Stuart Essig	Director	Sell	50,800	$47.76	$2,426,208.00
7/23/2014	Stuart Essig	Director	Sell	27,819	$47.80	$1,329,748.20
7/1/2014	Judith Ogrady	VP	Sell	2,500	$47.54	$118,850.00
6/23/2014	Stuart Essig	Director	Sell	21,381	$47.76	$1,021,156.56
4/3/2014	Stuart Essig	Director	Sell	6,344	$46.01	$291,887.44
4/2/2014	Stuart Essig	Director	Sell	76,177	$46.05	$3,507,950.85
3/31/2014	Stuart Essig	Director	Sell	17,479	$46.05	$804,907.95
3/10/2014	Deborah Leonetti	VP	Sell	7,563	$49.22	$372,250.86
3/4/2014	Richard Gorelick	VP	Sell	2,000	$47.98	$95,960.00
2/28/2014	Christian Schade	Director	Sell	7,500	$47.06	$352,950.00
2/27/2014	Brian Larkin	VP	Sell	3,265	$46.15	$150,679.75
2/27/2014	John Henneman III	CFO	Sell	5,000	$46.07	$230,350.00
1/16/2014	Stuart Essig	Director	Sell	8,037	$49.59	$398,554.83
1/14/2014	Stuart Essig	Director	Sell	10,600	$49.50	$524,700.00
1/13/2014	Stuart Essig	Director	Sell	99,032	$49.51	$4,903,074.32
1/9/2014	Stuart Essig	Director	Sell	114,431	$49.58	$5,673,488.98
8/30/2013	Richard Gorelick	VP	Sell	3,000	$40.79	$122,370.00
8/23/2013	Deborah Leonetti	VP	Sell	8,906	$41.68	$371,202.08
8/19/2013	Brian Larkin	VP	Sell	7,490	$41.90	$313,831.00
8/19/2013	John Henneman III	CFO	Sell	30,000	$42.08	$1,262,400.00
8/1/2013	Judith Ogrady	VP	Sell	1,000	$39.50	$39,500.00
7/30/2013	Judith Ogrady	VP	Sell	2,000	$38.50	$77,000.00
5/31/2013	Jerry E Corbin	VP	Sell	1,876	$38.07	$71,419.32

(Data available from 1/1/2013 forward)

Latest Headlines for Integra LifeSciences Holdings Corp. (NASDAQ:IART)

Date	Headline
	Strong Top And Bottom Line Growth Expected From Integra (NASDAQ:IART) finance.yahoo.com - September 23 at 5:12 PM
	Integra LifeSciences (IART) Announces First Usage of Cadence TAS in Europe (NASDAQ:IART) www.streetinsider.com - September 21 at 9:44 AM
	8:31 am Integra announces that the first three procedures using the its Cadence Total Ankle System in Europe were successfully completed since July 13, 2016 by Dr. Thibaut Leemrijse (NASDAQ:IART) finance.yahoo.com - September 20 at 10:41 AM
	Integra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe (NASDAQ:IART) www.publicnow.com - September 20 at 10:41 AM
	RS Investments Buys Allergan, Integra Lifesciences (NASDAQ:IART) finance.yahoo.com - September 15 at 5:53 PM
	Broker Price Targets: Integra LifeSciences Holdings Corporation (NASDAQ:IART) (NASDAQ:IART) www.nationaldailypress.com - September 15 at 5:53 PM
	FDA Expands Indication for Stryker’s Trevo Technology (NASDAQ:IART) marketrealist.com - September 15 at 5:53 PM
	Integra LifeSciences Holdings Corporation (NASDAQ:IART) Rating At 1.9 (NASDAQ:IART) www.stocksdaily.net - September 13 at 10:19 AM
	ETF’s with exposure to Integra LifeSciences Holdings Corp. : September 6, 2016 (NASDAQ:IART) www.capitalcube.com - September 6 at 5:32 PM
	Integra LifeSciences Holdings Corporation (NASDAQ:IART) Is Expected To Post EPS Of $1.02 (NASDAQ:IART) www.realistinvestor.com - September 3 at 5:01 PM
	Integra LifeSciences to Present at the Wells Fargo 2016 Healthcare Conference and the Morgan Stanley Global Healthcare Conference in September 2016 (NASDAQ:IART) www.publicnow.com - August 22 at 5:36 PM
	ETF’s with exposure to Integra LifeSciences Holdings Corp. : August 19, 2016 (NASDAQ:IART) www.capitalcube.com - August 19 at 5:31 PM
	Integra LifeSciences Holdings Corporation (IART) Hits New 52-week High During August 01 Session (NASDAQ:IART) www.equities.com - August 3 at 5:52 PM
	Integra LifeSciences Holdings Corporation (IART) Hits New 52-week High During August 01 Session (NASDAQ:IART) www.equities.com - August 3 at 5:52 PM
	Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:IART) www.capitalcube.com - August 3 at 5:52 PM
	Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:IART) www.capitalcube.com - August 3 at 5:52 PM
	Integra (IART) Tops Q2 Earnings, Grows Organically, Ups View (NASDAQ:IART) finance.yahoo.com - August 1 at 5:27 PM
	Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today (NASDAQ:IART) www.publicnow.com - August 1 at 8:41 AM
	Integra LifeSciences Holdings Reaches Analyst Target Price (NASDAQ:IART) www.nasdaq.com - July 30 at 5:03 PM
	Integra Lifesciences Holdings Corp. (NASDAQ:IART) stock price target bumped up to $84 as reported today by Barclays Capital (NASDAQ:IART) breakingfinancenews.com - July 30 at 5:03 PM
	INTEGRA LIFESCIENCES HOLDINGS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:IART) www.4-traders.com - July 28 at 8:32 AM
	Integra LifeSciences Raises 2016 Revenue Guidance (NASDAQ:IART) www.nasdaq.com - July 28 at 8:32 AM
	Integra Lifesciences Holdings Corp Q2 Profit Rises 21% (NASDAQ:IART) www.rttnews.com - July 28 at 8:32 AM
	Integra LifeSciences Holdings Corporation: Integra LifeSciences Reports Second Quarter 2016 Financial Results (NASDAQ:IART) www.twst.com - July 28 at 8:32 AM
	Q2 2016 Integra LifeSciences Holdings Corp Earnings Release - Before Market Open (NASDAQ:IART) biz.yahoo.com - July 28 at 7:07 AM
	Integra beats Street 2Q forecasts (NASDAQ:IART) sg.finance.yahoo.com - July 28 at 6:25 AM
	Integra LifeSciences Holdings Corporation (IART) Hits New 52-week High During July 11 Session (NASDAQ:IART) www.equities.com - July 13 at 5:55 PM
	Integra LifeSciences to Host Its Second Quarter 2016 Earnings Results Conference Call on July 28, 2016 (NASDAQ:IART) www.publicnow.com - July 11 at 4:33 PM
	Integra LifeSciences Holdings Corporation (IART) Hits New 52-week High During July 07 Session (NASDAQ:IART) www.equities.com - July 9 at 8:57 AM
	Integra LifeSciences Holdings Corporation (Nasdaq: IART) to Ring The Nasdaq Stock Market Closing Bell (NASDAQ:IART) finance.yahoo.com - July 5 at 10:00 AM
	Integra LifeSciences at 52-Week High on Solid Q1 Results (NASDAQ:IART) finance.yahoo.com - July 4 at 8:32 AM
	Integra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 30 Session (NASDAQ:IART) www.equities.com - July 3 at 5:08 PM
	Integra LifeSciences Holdings Larger Than S&P 500 Component Chesapeake Energy (NASDAQ:IART) www.marketnewsvideo.com - June 28 at 10:28 AM
	Integra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 - 17, 2016 in Lisbon, Portugal (NASDAQ:IART) www.publicnow.com - June 16 at 3:09 AM
	Integra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 09 Session (NASDAQ:IART) www.equities.com - June 12 at 8:18 AM
	Introducing Dentsply Sirona, a Leading Dental Products Manufacturer (NASDAQ:IART) marketrealist.com - June 10 at 5:41 PM
	Integra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 02 Session (NASDAQ:IART) www.equities.com - June 5 at 5:30 PM
	Shares Touching a Recent High: Integra LifeSciences Holdings Corporation (NASDAQ:IART) (NASDAQ:IART) bilbaoya.com - May 31 at 5:44 PM
	After Last Week What Do Analysts Think Of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Share Trading News (NASDAQ:IART) www.sharetrading.news - May 30 at 12:52 PM
	Integra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased By 9.86% - HNN (NASDAQ:IART) hintsnewsnetwork.com - May 29 at 12:04 PM
	8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls (NASDAQ:IART) 247wallst.com - May 28 at 9:40 AM
	INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:IART) biz.yahoo.com - May 26 at 4:16 PM
	Integra LifeSciences Holdings Corp (IART) Hits New 52-week High During May 23 Session - Equities.com (NASDAQ:IART) www.equities.com - May 26 at 11:23 AM
	Integra LifeSciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Healthcare Conference in May 2016 (NASDAQ:IART) www.publicnow.com - May 3 at 4:20 PM
	INTEGRA LIFESCIENCES HOLDINGS CORP Financials (NASDAQ:IART) finance.yahoo.com - May 3 at 1:04 PM
	Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:IART) www.capitalcube.com - May 2 at 1:13 PM
	Integra (IART) Beats on Q1 Earnings, Grows Organically (NASDAQ:IART) finance.yahoo.com - April 28 at 1:36 PM
	Edited Transcript of IART earnings conference call or presentation 27-Apr-16 12:30pm GMT (NASDAQ:IART) finance.yahoo.com - April 27 at 4:57 PM
	Q1 2016 Integra LifeSciences Holdings Corp Earnings Release - Before Market Open (NASDAQ:IART) biz.yahoo.com - April 27 at 7:07 AM
	Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch (NASDAQ:IART) www.publicnow.com - April 27 at 6:18 AM